Twist Bioscience Corp 8-K

What Happened
Twist Bioscience Corporation announced its financial results for the quarter ended March 31, 2026 in a press release dated May 4, 2026. The company furnished the full press release as Exhibit 99.1 to its Form 8-K filed under Item 2.02 (Results of Operations and Financial Condition).

Key Details

• Press release date: May 4, 2026; quarter covered: ended March 31, 2026.
• The press release is furnished as Exhibit 99.1 to the Form 8-K.
• Form 8-K was filed under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Exhibits).
• Report signed on behalf of the company by Judy Yan, Assistant General Counsel and Assistant Secretary.

Why It Matters
This filing signals Twist has publicly disclosed its latest quarterly earnings and related financial condition; investors should review the furnished press release (Exhibit 99.1) for revenue, earnings, and other metrics that could affect the stock. The Form 8-K provides timely disclosure of quarterly results under SEC rules, but the 8-K itself references the press release for the detailed financial figures.